Stocks · News reference

Anixa Biosciences To Present Data On Its Breast Cancer Vaccine At 2026 Cantor Fitzgerald Global Healthcare Conference

Aug 24, 2026, 12:57 PMBenzinga Newsdesk

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Aug 24, 2026, 12:57 PM
Checked: Aug 24, 2026, 1:28 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaJul 14, 2026, 12:35 PMBenzinga Newsdesk
Anixa Biosciences Issued Notice Of Acceptance From IP Australia For Its Breast Cancer Vaccine Technology
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that IP Australia has issued a Notice of
Read original at benzinga
ANIX
BenzingaJul 6, 2026, 12:36 PMBenzinga Newsdesk
Anixa Biosciences Doses First Participant In Fifth Group Of Its Phase 1 Clinical Study Of CAR-T/CER-T Therapy For Recurrent Ovarian Cancer
Read original at benzinga
ANIX
BenzingaJun 29, 2026, 12:46 PMBenzinga Newsdesk
Anixa Biosciences Receives Patent From South Korea's Ministry Of Intellectual Property For Its Breast Cancer Vaccine Technology
Read original at benzinga
ANIX